Ticker Details
Inhibrx, Inc.
IPO Date:	August 19, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.26B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.15 | 3.72%
Avg Daily Range (30 D):	$2.16 | 2.36%
Avg Daily Range (90 D):	$3.78 | 3.82%

Institutional Daily Volume
Avg Daily Volume:	.25M
Avg Daily Volume (30 D):	.21M
Avg Daily Volume (90 D):	.3M

Trade Size
Avg Trade Size (Sh.):	60
Avg Trade Size (Sh.) (30 D):	38
Avg Trade Size (Sh.) (90 D):	40

Institutional Trades
Total Institutional Trades:	1,509
Avg Institutional Trade:	$2.46M
Avg Institutional Trade (30 D):	$3.95M
Avg Institutional Trade (90 D):	$4.8M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.37M
Avg Closing Trade (30 D):	$3.43M
Avg Closing Trade (90 D):	$3.84M
Avg Closing Volume:	71.13K

News

May 14, 2026 @ 8:02 PM Inhibrx Reports First Quarter 2026 Financial Resul... Source: Prnewswire

Apr 22, 2026 @ 6:20 PM Large Drugmakers Eye Inhibrx Cancer Drugs Valued O... Source: Vandana Singh

Oct 24, 2025 @ 5:22 PM Stocks Soar To Records After Weak Inflation, Ford ... Source: Piero Cingari

Oct 24, 2025 @ 7:05 AM Why Are Inhibrx Biosciences Shares Soaring 76% Aft... Source: Mohd Haider

Jul 23, 2024 @ 9:01 AM Inhibrx stock rated 'Market Perform' by JMP after ... Source: Emilio Ghigini

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-8.39	$-2.15	$-2.11
Diluted EPS	$-8.39	$-2.15	$-2.11
Revenue	$1.3M	$M	$M
Gross Profit
Net Income / Loss	$-130.19M	$-33.44M	$-32.83M
Operating Income / Loss	$-123.05M	$-30.93M	$-30.92M
Cost of Revenue
Net Cash Flow	$-92.3M	$M	$-28.87M
PE Ratio